Pharvaris N.V. (PHVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 287,323 | 112,664 |
| Receivables | 653 | 651 |
| Income taxes - deferred | 125 | N/A |
| Other current assets | 6,034 | 2,116 |
| TOTAL | $294,134 | $115,431 |
| Non-Current Assets | ||
| PPE Net | 67 | 65 |
| TOTAL | $67 | $65 |
| Total Assets | $294,201 | $115,486 |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 5,203 | 967 |
| Accrued Expenses | 4,986 | 5,102 |
| TOTAL | $10,190 | $6,070 |
| Non-Current Liabilities | ||
| TOTAL | $N/A | $N/A |
| Total Liabilities | $10,190 | $6,070 |
| Shareholders' Equity | ||
| Common Shares | 4,788 | 269 |
| Retained earnings | -61,166 | -50,787 |
| Other shareholders' equity | 4,868 | 2,257 |
| TOTAL | $284,012 | $109,416 |
| Total Liabilities And Equity | $294,201 | $115,486 |